Concepedia

Stephanie Aungst

SA

Statistics

Publications

10

Citations

922

H-Index

10

Active since

2011

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

University of Maryland, Baltimore

Stephanie Aungst is an author at United States Food and Drug Administration specializing in medicine, neuroinflammation, and neurophysiology.

ORCID

Top concepts

Publications per year

2011–2025

10

Publications

10

Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury

Chinmoy Sarkar, Zaorui Zhao, Stephanie Aungst et al. · Autophagy · 2014 · 340 citations · Full text

Repeated Mild Traumatic Brain Injury Causes Chronic Neuroinflammation, Changes in Hippocampal Synaptic Plasticity, and Associated Cognitive Deficits

Stephanie Aungst, Shruti V. Kabadi, Scott M. Thompson et al. · Journal of Cerebral Blood Flow & Metabolism · 2014 · 247 citations · Full text

, , +30

FDA Approval Summary: Entrectinib for the Treatment of <i>NTRK</i> gene Fusion Solid Tumors

Leigh Marcus, Martha Donoghue, Stephanie Aungst et al. · Clinical Cancer Research · 2020 · 120 citations · Full text

FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine–Refractory Differentiated Thyroid Cancer

Abhilasha Nair, Steven J. Lemery, Jun Yang et al. · Clinical Cancer Research · 2015 · 76 citations

, , +17

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Katie Chon, Erin Larkins, Somak Chatterjee et al. · Clinical Cancer Research · 2023 · 48 citations · Full text

1–5 of 10